We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 41

Employment essentials - AugustSeptember 2016's top 5
  • Gowling WLG
  • United Kingdom
  • September 29 2016

On 18 August 2016, the Government Equalities Office published the consultation paper 'Closing the Public Sector Pay Gap' on extending the plans for


Two amendments to pharma legislation come into force
  • Gowling WLG
  • Canada
  • April 14 2011

The Amendments to The Food and Drug Regulations (1319- New Drugs For Extraordinary Use) came into force on March 25, 2011.


European generics pressing for global agreement on biosimilars
  • Gowling WLG
  • Global
  • September 21 2010

The European Generic Medicines Association (EGA) is pressing governments to draft a global agreement regarding the approval process for biosimilar medicines ("follow-on biologics").


Regulations for extraordinary use new drugs (EUNDs)
  • Gowling WLG
  • Canada
  • May 21 2010

Regulations to Amend the Food and Drug Regulations have been published, which would permit a new type of drug submission for certain types of drugs where there is a requirement to provide substantial evidence of safety and efficacy of the drug and, while there are ethical andor logistical challenges in designing appropriate clinical trials for a small number of emergency use drugs, such as anthrax and pandemic influenza vaccines.


Ontario government reforms to Ontario's prescription drug system announced
  • Gowling WLG
  • Canada
  • April 14 2010

On April 7, 2010, the McGuinty Government announced plans for further reforms to the prescription drug system in Ontario.


New U.K. Life Sciences Super Cluster
  • Gowling WLG
  • United Kingdom
  • February 12 2010

The U.K. government has recently announced their plans for a new U.K. Life Sciences Super Cluster - a scheme where industry, academia and the National Health Service work together to deliver new treatments for chronic disease.


U.S. drug prices challenged
  • Gowling WLG
  • USA
  • January 20 2010

In December, brand pharmaceutical companies defended themselves before the House Energy and Commerce health panel against complaints over reports, including one by the AARP (which represents 40 million older Americans), that drug prices continued to outstrip inflation in 2009.


Guidelines published to govern Ontario Emerging Technologies Fund
  • Gowling WLG
  • Canada
  • September 30 2009

Several months ago, the Ontario government announced that it was forming the Ontario Emerging Technologies Fund.


Federal Conservative "BioCaucus" - an excellent step
  • Gowling WLG
  • Canada
  • June 24 2009

The federal Conservative Party announced recently that a group of MPs, including the Minister of Industry, Tony Clement, have formed a "BioCaucus" to promote the opportunities and benefits of biotechnology in Canada.


Biotechnology clusters: their importance and keys to success
  • Gowling WLG
  • Canada
  • May 28 2009

The development of clusters as a key factor for the success of knowledge-based industries is not a new concept.